Mechanistically, YTHDF1 recognizes m6A-modified transcripts encoding lysosomal cathepsins in DCs and promotes their translation, which inhibits the cross-presentation of tumor neoantigens to achieve immune escape. The gene discussed is YTHDF1; the disease is neoplasm.